BRAF and cutaneous melanoma: All of the malignant skin melanoma cases showed immunoreactivity with BRAF V600E in immunohistochem- ical staining, 60% showed high intensity (score +3, Figure 1, 2) and the remaining 40% showed low intensity (score 1+ and 2+) (Figure 3, 4).